Drug development entails risk. Clinical trials are elaborate and expensive experiments, and unfortunately sometimes promising hypotheses prove false. This … Read more
Eric Venker, MD, PharmD, serves as Chief Operating Officer of Roivant Sciences. Venker first joined Roivant in 2014 and has since served in various roles of increasing responsibility, including chief of staff to the CEO. Prior to joining Roivant, Venker was a physician at New York Presbyterian Hospital, Columbia University Medical Center, where he trained in internal medicine. While there, he served as the Chair of the Housestaff Quality Council and led operational initiatives to improve efficiencies across a large hospital system with $5 billion in annual revenue. Earlier in his career, he was a Clinical Pharmacist at Yale-New Haven Hospital. He received his PharmD from St. Louis College of Pharmacy and his MD from Yale School of Medicine.